Basic Science and Pathogenesis
Basic Science and Pathogenesis
About this item
Full title
Basic Science and Pathogenesis
Author / Creator
Publisher
United States
Journal title
Alzheimer's & dementia, 2024-12, Vol.20 Suppl 1, p.e089820
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Anti- Aβ monoclonal antibodies are the first FDA-approved treatments for AD that slow cognitive decline and lower Aβ plaques. Our goal is to identify the epitope specificities of antibodies in human blood that are associated with AD and NC and determine the predicted protein targets of these antibodies.
101 AD (MMSE < 27) and 98 NC (MMSE > 27) s...
Alternative Titles
Full title
Basic Science and Pathogenesis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3151212453
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3151212453
Other Identifiers
ISSN
1552-5279
E-ISSN
1552-5279
DOI
10.1002/alz.089820
